Toews Corporation’s Bristol-Myers Squibb BMY Stock Holding History

Toews Corporation’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.91K	Buy	+172	New	+$9.88K	﹤0.01%	130
2023 Q4	–	Sell	-13,500	Closed	-$784K	–	26
2023 Q3	$784K	Buy	+13,500	New	+$827K	0.47%	15
2023 Q1	–	Sell	-10,500	Closed	-$755K	–	31
2022 Q4	$755K	Sell	10,500 -6,700	-39%	-$505K	0.37%	100
2022 Q3	$1.22M	Buy	17,200 +700	+4%	+$50.8K	0.9%	3
2022 Q2	$1.27M	Buy	16,500 +11,100	+206%	+$845K	0.85%	11
2022 Q1	$394K	Buy	+5,400	New	+$363K	0.07%	104
2021 Q4	–	Sell	-6,800	Closed	-$402K	–	38
2021 Q3	$402K	Buy	+6,800	New	+$448K	0.05%	97
2021 Q2	–	Sell	-14,800	Closed	-$934K	–	31
2021 Q1	$934K	Buy	+14,800	New	+$921K	0.08%	90
2020 Q4	–	Sell	-16,700	Closed	-$1.01M	–	36
2020 Q3	$1.01M	Buy	+16,700	New	+$1.01M	0.31%	30

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Toews Corporation's BMY Position: Q2 2026 in Review

Toews Corporation opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 172 shares worth $9.91K. The stake represents ﹤0.01% of the portfolio and ranks #130 among its holdings. This is a return to the name: Toews Corporation previously reported a position in BMY as recently as Q3 2023.

Toews Corporation first reported a position in BMY in Q3 2020 and has held it in 9 quarters since. The position peaked at $1.27M in Q2 2022. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Toews Corporation held 172 shares of Bristol-Myers Squibb worth $9.91K as of Q2 2026.
Bristol-Myers Squibb was a new Toews Corporation position in Q2 2026.
Bristol-Myers Squibb made up ﹤0.01% of Toews Corporation's portfolio in Q2 2026, its #130 holding.
Toews Corporation first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 9 quarters since.
Toews Corporation's Bristol-Myers Squibb position peaked at $1.27M in Q2 2022.
2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Toews Corporation's 13F filing for Q2 2026, filed 10 Aug 2026.